Your browser doesn't support javascript.
loading
Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections.
Lai, Rongtao; Zhou, Tianhui; Xiang, Xiaogang; Lu, Jie; Xin, Haiguang; Xie, Qing.
Afiliação
  • Lai R; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Zhou T; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Xiang X; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Lu J; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Xin H; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. allanxin@hotmail.com.
  • Xie Q; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. xieqingrjh@163.com.
Front Med ; 15(4): 644-648, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33909259
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Front Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Front Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China